Timeline
Deutsche Bank holds GSK at 1,900p as prescription tracker flags mixed product trends
Health & Bio Today: BSF Enterprise shares halve after T-Rex handbag fails at auction, Cizzle Biotechnology, GSK
GSK wins orphan drug status in US and Europe for momelotinib in rare inflammatory blood disorder with no approved treatments
GSK to buy Nuvalent for $10.6bn to add late‑stage lung‑cancer drugs
Health & Bio Today: GSK, BSF Enterprise, Nuformix, Physiomics, SkinBioTherapeutics, Property Franchise Group
GSK posts positive Phase 3 results for Hepatitis B treatment
Health & Bio Today: AstraZeneca wins dual FDA approvals, Advanced Medical Solutions, CelLBxHealth, GSK
GSK lands expanded approval for RSV vaccine Arexvy in Japan
GSK strikes exclusive China collab to roll out bepirovirsen
GSK cheers strong start to 2026, maintains FY guidance
GSK wins FDA priority review and breakthrough tag for bepirovirsen
GSK's efimosfermin sees FDA Breakthrough
GSK subsidiary TESARO has anticipatory breach claim dismissed by Delaware court
Tech Today: Advanced Medical Solutions in takeover talks, SEEEN, The Smarter Web Company, GSK
GSK wins China approval for Blenrep in 2L+ multiple myeloma
GSK completes acquisition of 35Pharma for $950m
GSK expands Arexvy approval to US adults 18–49 at increased risk
More in Telecoms
Vodafone Group shares soar after stake sale to Xavier Niel
French billionaire Xavier Niel is investing in Vodafone Group via his Vega entity, with funding provided entirely by Niel personally and financial institutions.